Treatment of pulmonary hypertension with carbonic anhydrase inhibitors
US8071557B2 · kind B2 · utility
2Cited by
4References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2007 |
| Grant date | Dec 6, 2011 |
| Priority date | — |
| Expiry date | Dec 27, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates generally to methods and pharmaceutical compositions useful in treating pulmonary hypertension. In one embodiment, for example, the disclosure provides a method for treating pulmonary hypertension comprising administering a therapeutically effective dose of a carbonic anhydrase inhibitor to a patient in need of treatment. The disclosure finds utility in the fields of medicine and pharmacology.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.